Related Experiment Video
Updated: Dec 20, 2025
06:58
Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
7.4K
Gut microbiota in reductive drug metabolism
Yukuang Guo1, Hyunwoo Lee1, Hyunyoung Jeong1
1Department of Pharmaceutical Sciences, Center for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.
Summary
Gut bacteria reduce various xenobiotics, including drugs, through specific metabolic pathways. This review highlights examples of drug reduction by gut bacteria, though enzyme functions and roles require further investigation.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Gut bacteria are key players in xenobiotic biotransformation within the gut microbiota.
- Reductive metabolism is a significant pathway by which gut bacteria modify xenobiotic compounds.
- Understanding these processes is crucial for drug efficacy and safety.
Purpose of the Study:
- To review the reductive metabolism of xenobiotics by gut bacteria.
- To provide examples of drugs undergoing reduction by gut bacteria across six chemical groups.
- To highlight the current understanding and gaps in knowledge regarding gut bacterial reductive enzymes.
Main Methods:
- Literature review of studies on gut bacteria and xenobiotic metabolism.
- Categorization of xenobiotics based on chemically distinct reductive groups (azo, nitro, alkene, ketone, N-oxide, sulfoxide).
- Selection of drug examples subjected to gut bacterial reduction.
Main Results:
- Gut bacteria mediate the reduction of xenobiotics through distinct chemical transformations.
- Examples of drugs across six chemical classes are identified as substrates for bacterial reduction.
- Enzymes responsible for reduction are identified for some drugs, but often only circumstantial evidence exists.
Conclusions:
- Gut bacteria play a vital role in the reductive metabolism of numerous drugs.
- Further research is needed to fully characterize the enzymes involved and their physiological significance.
- Elucidating these metabolic pathways can inform drug development and personalized medicine.
Related Concept Videos
01:27Phase I Reactions: Reductive Reactions
467
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
467
01:23Drug Elimination: Non-Renal Routes
2.9K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.9K
01:28Drug Biotransformation: Overview
2.3K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.3K
01:16Drug Biotransformation: Overview
3.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.4K
01:14Drug Metabolism: Phase II Reactions
4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
01:26Enhanced Elimination of Poison
778
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
778